-
ZSANQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Zosano Pharma (ZSANQ)
Company Profile
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 13.98 mm | 13.98 mm | 13.98 mm | 13.98 mm | 13.98 mm | 13.98 mm |
Cash burn (monthly) | (no burn) | 1.11 mm | 11.14 mm | 4.75 mm | 2.85 mm | 2.39 mm |
Cash used (since last report) | n/a | 39.03 mm | 390.62 mm | 166.67 mm | 99.85 mm | 83.80 mm |
Cash remaining | n/a | -25.05 mm | -376.63 mm | -152.69 mm | -85.87 mm | -69.82 mm |
Runway (months of cash) | n/a | -22.5 | -33.8 | -32.1 | -30.2 | -29.2 |
13F holders | Current |
---|---|
Total holders | 28 |
Opened positions | 5 |
Closed positions | 9 |
Increased positions | 9 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 2.69 mm |
Total shares | 11.93 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 5.15 mm | $1.16 mm |
Aisling Capital Management | 2.72 mm | $612.00 k |
BLK BlackRock | 2.05 mm | $462.00 k |
STT State Street | 436.34 k | $98.00 k |
Renaissance Technologies | 249.01 k | $56.00 k |
Telemetry Investments, L.L.C. | 210.00 k | $47.00 k |
NTRS Northern Trust | 199.50 k | $45.00 k |
BCS Barclays | 150.00 k | $34.00 k |
UBS UBS | 144.67 k | $32.00 k |
C Citigroup | 124.70 k | $28.00 k |